EMA Authorised: PecFent (fentanyl) — Gruenenthal GmbH

View source ↗

Summary

EMA authorizes PecFent (fentanyl) by Gruenenthal GmbH for pain and cancer indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Pain

Drugs mentioned

• Pecfent (fentanyl citrate)

Snippet

Status: Authorised. Therapeutic area: Pain;Cancer. MAH: Gruenenthal GmbH. Decision date: 26/02/2026